thymidine has been researched along with pd 184352 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, SJ; Nixon, PM; Squires, MS | 1 |
| Jiang, P; Omer, C; Przybranowski, S; Sebolt-Leopold, J; Van Becelaere, K; Wang, Y | 1 |
| Martin, L | 1 |
3 other study(ies) available for thymidine and pd 184352
| Article | Year |
|---|---|
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
Topics: Animals; Benzamides; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; Cell Line; Cricetinae; Cricetulus; DNA; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Mitogen-Activated Protein Kinases; Thymidine | 2002 |
A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040.
Topics: Agar; Animals; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epidermal Growth Factor; Immunoblotting; Immunoprecipitation; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins p21(ras); RNA; RNA, Complementary; Thymidine; Time Factors; Transfection; Up-Regulation | 2005 |
PD184352 releases the regular hypoxic reversible DNA replication arrest in T24 cells.
Topics: Benzamides; Cell Hypoxia; Cell Line, Tumor; DNA Replication; Humans; MAP Kinase Signaling System; Replicon; Thymidine | 2007 |